<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:44:53Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3378661" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3378661</identifier><datestamp>2012-07-01</datestamp><setSpec>wtpa</setSpec><setSpec>pmc-open</setSpec><setSpec>manuscript</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">9216904</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">2419</journal-id>
      <journal-id journal-id-type="nlm-ta">Nat Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat. Genet.</journal-id>
      <journal-title-group>
        <journal-title>Nature genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1061-4036</issn>
      <issn pub-type="epub">1546-1718</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3378661</article-id>
      <article-id pub-id-type="pmcid">PMC3378661</article-id>
      <article-id pub-id-type="pmc-uid">3378661</article-id>
      <article-id pub-id-type="pmid">22522421</article-id>
      <article-id pub-id-type="pmid">22522421</article-id>
      <article-id pub-id-type="doi">10.1038/ng.2253</article-id>
      <article-id pub-id-type="manuscript">wtpa47467</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in <italic>ISPD</italic> cause Walker-Warburg syndrome and defective glycosylation of Î±-dystroglycan</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Roscioli</surname>
            <given-names>Tony</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="author-notes" rid="FN1">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kamsteeg</surname>
            <given-names>Erik-Jan</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Buysse</surname>
            <given-names>Karen</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maystadt</surname>
            <given-names>Isabelle</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="author-notes" rid="FN1">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Reeuwijk</surname>
            <given-names>Jeroen</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van den Elzen</surname>
            <given-names>Christa</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Beusekom</surname>
            <given-names>Ellen</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Riemersma</surname>
            <given-names>Moniek</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pfundt</surname>
            <given-names>Rolph</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vissers</surname>
            <given-names>Lisenka E.L.M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schraders</surname>
            <given-names>Margit</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Altunoglu</surname>
            <given-names>Umut</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Buckley</surname>
            <given-names>Michael F.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brunner</surname>
            <given-names>Han G.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grisart</surname>
            <given-names>Bernard</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Huiqing</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Veltman</surname>
            <given-names>Joris A.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gilissen</surname>
            <given-names>Christian</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mancini</surname>
            <given-names>Grazia M.S.</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DelrÃ©e</surname>
            <given-names>Paul</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Willemsen</surname>
            <given-names>MichÃ¨l A.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>RamadÅ¾a</surname>
            <given-names>Danijela PetkoviÄ</given-names>
          </name>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chitayat</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="A9">9</xref>
          <xref ref-type="aff" rid="A10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bennett</surname>
            <given-names>Christopher</given-names>
          </name>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sheridan</surname>
            <given-names>Eamonn</given-names>
          </name>
          <xref ref-type="aff" rid="A11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peeters</surname>
            <given-names>Els A.J.</given-names>
          </name>
          <xref ref-type="aff" rid="A12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tan-Sindhunata</surname>
            <given-names>Gita M.B.</given-names>
          </name>
          <xref ref-type="aff" rid="A13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Die-Smulders</surname>
            <given-names>Christine E.</given-names>
          </name>
          <xref ref-type="aff" rid="A14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Devriendt</surname>
            <given-names>Koenraad</given-names>
          </name>
          <xref ref-type="aff" rid="A15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kayserili</surname>
            <given-names>HÃ¼lya</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>El-Hashash</surname>
            <given-names>Osama Abd El-Fattah</given-names>
          </name>
          <xref ref-type="aff" rid="A16">16</xref>
          <xref ref-type="aff" rid="A17">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stemple</surname>
            <given-names>Derek L.</given-names>
          </name>
          <xref ref-type="aff" rid="A18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lefeber</surname>
            <given-names>Dirk J.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="aff" rid="A19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Yung-Yao</given-names>
          </name>
          <xref ref-type="aff" rid="A18">18</xref>
          <xref ref-type="author-notes" rid="FN2">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van Bokhoven</surname>
            <given-names>Hans</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN2">21</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
</aff>
      <aff id="A2"><label>2</label>School of Womenâs and Childrenâs Health, Sydney Childrenâs hospital and the University of New South Wales, Sydney, Australia
</aff>
      <aff id="A3"><label>3</label>Centre de GÃ©nÃ©tique Humaine, Institut de Pathologie et de GÃ©nÃ©tique, Gosselies, Belgium
</aff>
      <aff id="A4"><label>4</label>Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
</aff>
      <aff id="A5"><label>5</label>Department of Otorhinolaryngology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen
</aff>
      <aff id="A6"><label>6</label>Medical Genetics Department, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
</aff>
      <aff id="A7"><label>7</label>Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands
</aff>
      <aff id="A8"><label>8</label>Department of Pediatrics, University Hospital Centre, Zagreb, Croatia
</aff>
      <aff id="A9"><label>9</label>Mount Sinai Hospital, The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Canada
</aff>
      <aff id="A10"><label>10</label>The Hospital for Sick Children, Division of Clinical and Metabolic Genetics, Toronto, Canada
</aff>
      <aff id="A11"><label>11</label>Department of Clinical Genetics, St Jamesâs University Hospital, Leeds, United Kingdom
</aff>
      <aff id="A12"><label>12</label>Medisch Centrum Haaglanden, Den Haag, The Netherlands
</aff>
      <aff id="A13"><label>13</label>Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands
</aff>
      <aff id="A14"><label>14</label>Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands
</aff>
      <aff id="A15"><label>15</label>Center for Human Genetics, Clinical Genetics, Catholic University Leuven, Leuven, Belgium
</aff>
      <aff id="A16"><label>16</label>Pediatric department, Farwaniya Hospital, Kuwait City, Kuwait
</aff>
      <aff id="A17"><label>17</label>Ministry of Health, Cairo, Egypt
</aff>
      <aff id="A18"><label>18</label>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom
</aff>
      <aff id="A19"><label>19</label>Laboratory for Genetic, Endocrine and Metabolic Disease, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
</aff>
      <author-notes>
        <fn fn-type="equal" id="FN1">
          <label>20</label>
          <p id="P1">These authors contributed equally to this work</p>
        </fn>
        <fn fn-type="equal" id="FN2">
          <label>21</label>
          <p id="P2">These authors jointly directed this work.</p>
        </fn>
        <corresp id="CR1"><bold>Correspondence:</bold> Yung-Yao Lin, PhD, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom, and Hans van Bokhoven, PhD, Department of Human Genetics 855, Radboud University Nijmegen Medical Centre, Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. <email>YYL@sanger.ac.uk</email> &amp; <email>H.vanbokhoven@gen.umcn.nl</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>2</day>
        <month>4</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>7</month>
        <year>2012</year>
      </pub-date>
      <volume>44</volume>
      <issue>5</issue>
      <fpage>581</fpage>
      <lpage>585</lpage>
      <permissions>
        <license>
          <license-p>Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
<uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
        </license>
      </permissions>
      <abstract>
        <p id="P3">Walker-Warburg syndrome (WWS) is an autosomal recessive multisystem disorder characterized by complex eye and brain abnormalities with congenital muscular dystrophy (CMD) and aberrant Î±-dystroglycan (Î±DG) glycosylation. Here, we report mutations in the <italic>isoprenoid synthase domain-containing (ISPD</italic>) gene as the second most common cause of WWS. Bacterial IspD is a nucleotidyl transferase belonging to a large glycosyltransferase family, but its role in chordates has been obscure to date because this phylum does not have the corresponding non-mevalonate isoprenoid biosynthesis pathway. Knockdown of <italic>ispd</italic> in zebrafish recapitulates the human WWS phenotype with hydrocephalus, reduced eye size, muscle degeneration and hypoglycosylated Î±DG. These results implicate a role for ISPD in Î±DG glycosylation to maintain sarcolemma integrity in vertebrates.</p>
      </abstract>
      <funding-group>
        <award-group>
          <funding-source country="United Kingdom">Wellcome Trust : </funding-source>
          <award-id>077037 || WT</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <p id="P4">Defective O-linked glycosylation of Î±DG is the characteristic feature of a clinically and genetically heterogeneous group of disorders, commonly referred to as dystroglycanopathies. This group of diseases is characterized by a broad phenotypic spectrum ranging from severe forms of CMD with eye involvement, cerebral malformations and intellectual disability including WWS and Muscle Eye Brain disease (MEB), to milder adult-onset phenotypes without central nervous system involvement such as limb girdle muscular dystrophy (LGMD) type 2I<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Mutations in six genes, <italic>POMT1</italic>, <italic>POMT2</italic>, <italic>POMGnT1</italic>, <italic>FKTN</italic>, <italic>FKRP</italic> and <italic>LARGE</italic>, encoding proteins involved in the post-translational modification of Î±DG, have been implicated in WWS and other dystroglycanopathies<sup><xref ref-type="bibr" rid="R1">1</xref>-<xref ref-type="bibr" rid="R10">10</xref></sup>. Mutations in these six genes represent 35% of WWS incidence, suggesting that additional WWS genes await discovery. At the milder end of the dystroglycanopathy disease spectrum single patients have been reported with Î±DG hypoglycosylation due to a missense mutation in either the dystroglycan gene (<italic>DAG1</italic>)<sup><xref ref-type="bibr" rid="R11">11</xref></sup> or the <italic>DPM3</italic> gene<sup><xref ref-type="bibr" rid="R12">12</xref></sup>, the latter leading to reduced levels of dolichol-P-mannose donor for O-mannosylation<sup><xref ref-type="bibr" rid="R12">12</xref></sup>. The factors determining dystroglycanopathy phenotypes are not well understood, but may involve the extent of residual glycosylation of Î±DG<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R13">13</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup> and other proteins<sup><xref ref-type="bibr" rid="R15">15</xref>-<xref ref-type="bibr" rid="R17">17</xref></sup>. Identifying novel causative genes will shed light on the pathological mechanisms of WWS and other dystroglycanopathies.</p>
    <p id="P5">To identify novel genes that are involved in WWS, we selected a cohort of 59 patients with idiopathic WWS in whom mutations in the known dystroglycanopathy genes had been previously excluded. Thirty of these patients, the majority of whom came from consanguineous families, were genotyped using the Affymetrix GeneChip Human Mapping 250K SNP <italic>Nsp</italic>I Array to identify copy number variants (CNVs) and homozygous regions. SNP haplotyping detected a large number of non-overlapping homozygous regions amongst these patients, providing support for further genetic heterogeneity in WWS (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 1</xref>). Interestingly, the corresponding CNV profiles identified two homozygous deletions affecting the <italic>ISPD</italic> gene (patients WWS-160 and WWS-161, <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 2</xref>), suggesting that <italic>ISPD</italic> is a strong candidate for WWS, as there were no other overlapping CNV regions present in the patient cohort. Another family (WWS-25; for pedigree see <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 3a</xref>) was identified with two siblings and a cousin affected with WWS who shared a 3.5 Mb homozygous region on chromosome 7p21 containing ten genes including <italic>ISPD</italic> (<xref ref-type="fig" rid="F1">Fig. 1a</xref>). One of these siblings was investigated by exome sequencing and after filtering based on an autosomal recessive pattern of inheritance according to methods described previously<sup><xref ref-type="bibr" rid="R18">18</xref></sup>, a single homozygous variant was identified in this region of shared homozygosity. This c.647C&gt;A transversion in exon 3 of <italic>ISPD</italic> (NM_001101426.3), predicting a p.Ala216Asp substitution, showed complete segregation in the family, being present in the homozygous state in the other two affected individuals, in the heterozygous state in both parental couples and absent in healthy or deceased siblings with another phenotype.</p>
    <p id="P6">Next, we sequenced the ten coding exons of <italic>ISPD</italic> in the WWS patient cohort and identified missense, nonsense and frameshift mutations in an additional five individuals from five families (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 3</xref>). In addition, failure to PCR-amplify exons 3 to 5 in family WWS-37, suggested the presence of a homozygous intragenic microdeletion, which was confirmed by quantitative MLPA analysis (data not shown). An overview of all identified mutations is given in <xref ref-type="table" rid="T1">Table 1</xref> and a schematic representation of their localization is shown in <xref ref-type="fig" rid="F1">Figure 1a</xref>. In summary, mutations affecting <italic>ISPD</italic> were detected in 9 out of 94 families, accounting for an overall percentage of 10% (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). All mutations showed a segregation pattern expected for causative recessive mutations in family members available for testing and were absent in a control cohort of 3712 haploid genomes. The three nonsense mutations, p.Arg268*, p.Lys278* and p.Glu396*, are predicted to give rise to nonsense-mediated mRNA decay or truncation of the protein. The three missense mutations (p.Ala216Asp, p.Arg126His and p.Ala122Pro) are located within the ISPD domain (<xref ref-type="fig" rid="F1">Fig. 1a</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 4a</xref>), a conserved domain of a large GT-A glycosyltransferase family that also includes nucleotidyltransferases<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. Both p.Ala216Asp and p.Arg126His affect highly conserved amino acids and are predicted to be damaging by PolyPhen2, whereas p.Ala122Pro is predicted to be probably damaging. <italic>In silico</italic> modeling based on an <italic>E. coli</italic> IspD crystal structure using the HOPE web server (see URLs) predicted charge and size differences between the wild-type and mutant amino acids that are likely to affect protein folding and disruption of the CTP-binding pocket for mutations p.Ala122Pro and p.Arg126His (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 4b</xref>).</p>
    <p id="P7">All affected individuals with <italic>ISPD</italic> mutations had a severe WWS-like phenotype with only two out of 11 surviving beyond two years of age with brain anomalies that are more indicative of MEB (WWS-81 and -163; <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Routine cerebral MRI (<xref ref-type="fig" rid="F2">Fig. 2a and 2b</xref>) showed typical features of cobblestone lissencephaly together with hydrocephalus, cerebellar hypoplasia and a kinked brainstem. Muscle histology and immunohistochemistry showed dystrophic changes and clear reduction of glycosylated Î±DG by the IIH6 antibody, which recognizes an unknown glyco-epitope on Î±DG<sup><xref ref-type="bibr" rid="R20">20</xref></sup> (patients from families WWS-25, -160, and -81) (<xref ref-type="fig" rid="F2">Fig. 2c-f</xref>).</p>
    <p id="P8">The function of ISPD in vertebrates is unknown. In view of the significant conservation of protein sequences (65% amino acid similarity) between the zebrafish (<italic>Danio rerio</italic>) and human orthologs, we determined the effects of loss of function of zebrafish <italic>ispd</italic>, which encodes two isoforms that differ only in their N-termini. To do this, we knocked down both <italic>ispd</italic> isoforms with antisense morpholino oligonucleotides (MO), targeting exon-intron splice sites common to both transcripts (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 5</xref>). High doses of <italic>ispd</italic> MO1 (7 ng) caused hydrocephalus and incomplete brain folding in 82% of embryos (n=88) by 48 hours post fertilization (h.p.f.) (<xref ref-type="fig" rid="F3">Fig. 3a</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 6</xref>), as well as significantly reduced eye size reminiscent of microphthalmia in WWS patients (<xref ref-type="fig" rid="F3">Fig. 3b and 3c</xref>). Other phenotypic features included impaired motility and myotome lesions (data not shown). Injection of <italic>ispd</italic> MO2 (3 ng) caused similar morphological abnormalities, assuring the specificity of both MOs (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7</xref>). We looked for structural defects in muscle fibers by labeling sarcolemma with membrane-localized red fluorescent protein (mRFP) and filamentous-actin (F-actin) with phalloidin. <italic>ispd</italic> MO1-injected embryos showed muscle fiber degeneration by 72 h.p.f. (<xref ref-type="fig" rid="F3">Fig. 3d</xref>) and, in some cases, disruption of myotendinous junctions (MTJ; 45%, n=31), exemplified by elongated muscle fibers spanning MTJ (<xref ref-type="fig" rid="F3">Fig. 3d</xref>). Together, these results suggest that zebrafish <italic>ispd</italic> knockdown embryos recapitulate the major aspects of human WWS pathology.</p>
    <p id="P9">Hypoglycosylation of Î±DG is a diagnostic characteristic of WWS. To test if knockdown of <italic>ispd</italic> in zebrafish also affects glycosylation of Î±DG, we performed western blotting with the IIH6 antibody<sup><xref ref-type="bibr" rid="R20">20</xref></sup>. Compared with control embryos, glycosylated Î±DG was reduced in <italic>ispd</italic> MO1-injected zebrafish embryos (<xref ref-type="fig" rid="F4">Fig. 4a</xref>). Given the similarity of MTJ disruption observed in <italic>ispd</italic> MO1-injected embryos and zebrafish laminin mutants<sup><xref ref-type="bibr" rid="R21">21</xref>,<xref ref-type="bibr" rid="R22">22</xref></sup>, the localization of laminins was assessed. Despite the severe muscle fiber degeneration, laminins remained localized to the MTJ in <italic>ispd</italic> MO1-injected embryos (<xref ref-type="fig" rid="F4">Fig. 4b</xref>). Subsequently, we assessed the sarcolemma integrity in embryos injected with either <italic>ispd</italic> MO using Evans blue dye (EBD). Intact sarcolemma is impermeable to EBD. We found that MTJ-anchored muscle fibers were infiltrated by EBD before the onset of muscle degeneration at 48 h.p.f. (<xref ref-type="fig" rid="F4">Fig. 4c</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 7c</xref>). Muscle pathology became evident as EBD-infiltrated muscle fibers retracted during muscle degeneration. The posterior myotome of <italic>ispd</italic> MO1-injected embryos was more susceptible to sarcolemma damage than the anterior myotome (<xref ref-type="fig" rid="F4">Fig. 4c</xref>). As sarcolemma damage was reported in dystrophin-deficient models<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref></sup>, we assessed the immunoreactivity of dystrophin in <italic>ispd</italic> MO1-injected embryos. No obvious alterations to dystrophin immunoreactivity were detected (data not shown). Together, these results demonstrate an important WWS pathogenic mechanism, independent from laminin and dystrophin, in which loss of Ispd function in zebrafish results in Î±DG hypoglycosylation and compromised sarcolemma integrity, preceding muscle fiber degeneration.</p>
    <p id="P10">In plants, protozoa and some bacteria, ISPD belongs to the non-mevalonate isoprenoid biosynthesis (MEP) pathway, which is absent in vertebrates<sup><xref ref-type="bibr" rid="R25">25</xref></sup>. Prokaryotic IspD has cytidyltransferase activity using 2-C-methyl-D erythritol as substrate for the synthesis of the nucleotide sugar CDP-methyl-erythritol. The structurally homologous TarI in <italic>Streptococcus pneumoniae</italic>, lacking the MEP pathway, uses ribitol-1-phosphate to produce an activated nucleotide sugar (CDP-ribitol) used for incorporation in polysaccharides<sup><xref ref-type="bibr" rid="R26">26</xref></sup>. Analogous to the role of DPM3, it is likely that human ISPD synthesises a novel nucleotide sugar, the exact nature of which remains to be determined. Glycosyltransferases could use such nucleotide-activated building blocks for incorporation into the Î±DG O-mannosyl glycan. Intriguingly, the bacterium <italic>Prevotella tannerae</italic> expresses a gene (accession number ZP_05736246) with both IspD and LicD (<italic>li</italic>popolysaccharide <italic>c</italic>ore <italic>D</italic>) domains, which may act sequentially in the post-translational modifications. The LicD domain is also found in the putative glycosyltransferases, FKTN and FKRP, both involved in the glycosylation of Î±DG. Thus, it appears that the ISPD and LicD domains that are both contained in a prokaryotic precursor protein are dispersed over the vertebrate ISPD and FKTN/FKRP proteins, respectively. We sought to test the possibility of genetic interactions between these genes. Co-injection of sub-effective doses of <italic>ispd</italic> MO1 with <italic>fktn</italic> or <italic>fkrp</italic> MO showed a marked increase in the proportion of embryos with hydrocephalus (68% and 49% respectively, compared with 3% in control MO and <italic>ispd</italic> MO1 co-injection; <xref ref-type="fig" rid="F4">Fig. 4d</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8a</xref>). The same effect was seen using <italic>ispd</italic> MO2, confirming specificity (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8</xref>). Moreover, glycosylation of Î±DG is reduced in the embryos co-injected with <italic>ispd</italic> MO1 and <italic>fktn/fkrp</italic> MO as compared to embryos co-injected with <italic>ispd</italic> MO1 and control MO, and single <italic>fktn/fkrp</italic> MO-injected embryos (<xref ref-type="fig" rid="F4">Fig. 4e</xref>). These results support a cooperative interaction between <italic>ispd</italic> and <italic>fktn/fkrp</italic> in Î±DG glycosylation.</p>
    <p id="P11">In conclusion, our findings provide evidence for a significant contribution of <italic>ISPD</italic> mutations to the prevalence of WWS. We report the identification of <italic>ISPD</italic> mutations in nine WWS families. Due to the high frequency of <italic>ISPD</italic> mutations in this WWS cohort (15% of pre-screened patients, 10% overall, <xref ref-type="fig" rid="F1">Fig. 1b</xref>), we recommend that <italic>ISPD</italic> mutation analysis should be performed as part of routine molecular diagnostic testing in WWS. With the identification of ISPD, we can now explain almost 50% of all WWS of our cohort. The results of homozygosity mapping indicate the existence of several additional loci. Given that most of the remaining patients represent isolated cases, we anticipate that exome sequencing will be the strategy of choice to resolve additional genes and to unravel the complex post-translational modification pathways that are key to normal brain and muscular development.</p>
    <sec sec-type="supplementary-material" id="SM">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <label>Supplementary Information</label>
        <media xlink:href="NIHMS47467-supplement-1.pdf" orientation="portrait" xlink:type="simple" id="d35e846" position="anchor" mimetype="application" mime-subtype="pdf"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <label>Online Methods</label>
        <media xlink:href="NIHMS47467-supplement-02.pdf" orientation="portrait" xlink:type="simple" id="d35e850" position="anchor" mimetype="application" mime-subtype="pdf"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S1">
      <title>ACKNOWLEDGEMENTS</title>
      <p>We thank all family members who participated in this study. We would also like to thank A. Charon, Service de PÃ©diatrie, Grand HÃ´pital de Charleroi, Charleroi, Belgium for referring an affected patient, G. Powell and S. Gerety for critical comments on the manuscript and R. Schot for study of the deletion in family WWS-161. This project was supported by the Large-Scale Integrating Project GENCODYS-Genetic and Epigenetic Networks in Cognitive DYSfunction (241995), which is funded by the EU FP7 Health program (HvB), the Australian NHMRC with an overseas post-doctoral fellowship (TR), The Prinses Beatrix Fund (grant W.OR09-15 to DL and HvB), the Hersenstichting Nederland (HvB), and an EMBO Long-Term Fellowship (ALTF 805-2009 to KB). All zebrafish work was sponsored by the Wellcome Trust [grant number WT 077047/Z/05/Z] and [grant number WT 077037/Z/05/Z]. NGS experiments were financially supported by the Department of Human Genetics, Nijmegen, The Netherlands, as well as by the Netherlands Organization for Health Research and Development (ZonMW grant 916-86-016 to LELMV).</p>
    </ack>
    <fn-group>
      <fn id="FN3">
        <p id="P12"><bold>URLs</bold> UCSC Genome Bioinformatics, <ext-link ext-link-type="uri" xlink:href="http://www.genome.ucsc.edu/">http://www.genome.ucsc.edu/</ext-link>; OMIM and Unigene, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link>; Ensembl, <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/index.html">http://www.ensembl.org/index.html</ext-link>; PolyPhen2 <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>; Project HOPE <ext-link ext-link-type="uri" xlink:href="http://www.cmbi.ru.nl/hope/home">http://www.cmbi.ru.nl/hope/home</ext-link>; Exome Variant Server <ext-link ext-link-type="uri" xlink:href="http://snp.gs.washington.edu/EVS/">http://snp.gs.washington.edu/EVS/</ext-link>; ZFIN <ext-link ext-link-type="uri" xlink:href="http://www.zfin.org/">http://www.zfin.org/</ext-link></p>
      </fn>
      <fn id="FN4">
        <p id="P13"><bold>AUTHOR CONTRIBUTIONS</bold> The study was designed and the results were interpreted by T.R., K.B., D.L.S., Y.Y.L., H.G.B., D.J.L. and H.V.B. Subject ascertainment and recruitment was carried out by I.M., U.A., B.G., G.M.S.M., P.D., M.A.W., D.P.R., D.C., C.B., E.S., E.A.J.P., G.M.B.T.S., C.E.D.D.S., K.D., H.K., O.A.E.F.E.H., and H.V.B. Sequencing, CNV analysis and genotyping was carried out and interpreted by T.R., E.J.K., K.B., I.M., J.V.R., C.V.D.E., E.V.B., M.R., R.P., L.E.L.M.V., M.S., M.F.B., H.Z., J.A.V., C.G., G.M.S.M., and H.V.B. Zebrafish studies were designed and carried out by K.B., D.L.S. and Y.Y.L. Bioinformatic data analysis and protein modeling was done by T.R., J.V.R., C.G., and D.J.L. The manuscript was drafted by T.R., K.B., D.J.L., Y.Y.L. and H.V.B. All authors contributed to the final version of the paper.</p>
      </fn>
      <fn id="FN5">
        <p id="P14"><bold>COMPETING FINANCIAL INTERESTS</bold> The authors declare that they have no competing financial interests.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Reeuwijk</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brunner</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>van Bokhoven</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Glyc-O-genetics of Walker-Warburg syndrome</article-title>
          <source>Clin Genet</source>
          <year>2005</year>
          <volume>67</volume>
          <fpage>281</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15733261</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kobayashi</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy</article-title>
          <source>Nature</source>
          <year>1998</year>
          <volume>394</volume>
          <fpage>388</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">9690476</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1</article-title>
          <source>Dev Cell</source>
          <year>2001</year>
          <volume>1</volume>
          <fpage>717</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">11709191</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beltran-Valero de Bernabe</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome</article-title>
          <source>Am J Hum Genet</source>
          <year>2002</year>
          <volume>71</volume>
          <fpage>1033</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">12369018</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brockington</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan</article-title>
          <source>Am J Hum Genet</source>
          <year>2001</year>
          <volume>69</volume>
          <fpage>1198</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="pmid">11592034</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Longman</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan</article-title>
          <source>Hum Mol Genet</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>2853</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">12966029</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beltran-Valero de Bernabe</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome</article-title>
          <source>J Med Genet</source>
          <year>2004</year>
          <volume>41</volume>
          <fpage>e61</fpage>
          <pub-id pub-id-type="pmid">15121789</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Reeuwijk</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome</article-title>
          <source>J Med Genet</source>
          <year>2005</year>
          <volume>42</volume>
          <fpage>907</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">15894594</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Reeuwijk</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome</article-title>
          <source>Hum Genet</source>
          <year>2007</year>
          <volume>121</volume>
          <fpage>685</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">17436019</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silan</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A new mutation of the fukutin gene in a non-Japanese patient</article-title>
          <source>Ann Neurol</source>
          <year>2003</year>
          <volume>53</volume>
          <fpage>392</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">12601708</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hara</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A dystroglycan mutation associated with limb-girdle muscular dystrophy</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>364</volume>
          <fpage>939</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="pmid">21388311</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lefeber</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies</article-title>
          <source>Am J Hum Genet</source>
          <year>2009</year>
          <volume>85</volume>
          <fpage>76</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">19576565</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Godfrey</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan</article-title>
          <source>Brain</source>
          <year>2007</year>
          <volume>130</volume>
          <fpage>2725</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">17878207</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jimenez-Mallebrera</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity</article-title>
          <source>Brain Pathol</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>596</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="pmid">18691338</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>YY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies</article-title>
          <source>Hum Mol Genet</source>
          <year>2011</year>
          <volume>20</volume>
          <fpage>1763</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">21317159</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>LARGE expression augments the glycosylation of glycoproteins in addition to alpha-dystroglycan conferring laminin binding</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e19080</fpage>
          <pub-id pub-id-type="pmid">21533062</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bleckmann</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>O-glycosylation pattern of CD24 from mouse brain</article-title>
          <source>Biol Chem</source>
          <year>2009</year>
          <volume>390</volume>
          <fpage>627</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">19284289</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilissen</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome</article-title>
          <source>Am J Hum Genet</source>
          <year>2010</year>
          <volume>87</volume>
          <fpage>418</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">20817137</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mushegian</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Three monophyletic superfamilies account for the majority of the known glycosyltransferases</article-title>
          <source>Protein Sci</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>1418</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">12824488</pub-id>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michele</surname>
              <given-names>DE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies</article-title>
          <source>Nature</source>
          <year>2002</year>
          <volume>418</volume>
          <fpage>417</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">12140558</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snow</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Time-lapse analysis and mathematical characterization elucidate novel mechanisms underlying muscle morphogenesis</article-title>
          <source>PLoS Genet</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>e1000219</fpage>
          <pub-id pub-id-type="pmid">18833302</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parsons</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Zebrafish mutants identify an essential role for laminins in notochord formation</article-title>
          <source>Development</source>
          <year>2002</year>
          <volume>129</volume>
          <fpage>3137</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="pmid">12070089</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bassett</surname>
              <given-names>DI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo</article-title>
          <source>Development</source>
          <year>2003</year>
          <volume>130</volume>
          <fpage>5851</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">14573513</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Straub</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rafael</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Chamberlain</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>KP</given-names>
            </name>
          </person-group>
          <article-title>Animal models for muscular dystrophy show different patterns of sarcolemmal disruption</article-title>
          <source>J Cell Biol</source>
          <year>1997</year>
          <volume>139</volume>
          <fpage>375</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">9334342</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richard</surname>
              <given-names>SB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Kinetic analysis of Escherichia coli 2-C-methyl-D-erythritol-4-phosphate cytidyltransferase, wild type and mutants, reveals roles of active site amino acids</article-title>
          <source>Biochemistry</source>
          <year>2004</year>
          <volume>43</volume>
          <fpage>12189</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">15379557</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baur</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marles-Wright</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Buckenmaier</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Vollmer</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae</article-title>
          <source>J Bacteriol</source>
          <year>2009</year>
          <volume>191</volume>
          <fpage>1200</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">19074383</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacLeod</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycoprotein complex</article-title>
          <source>Neuromuscul Disord</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>285</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17336067</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wood</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency</article-title>
          <source>Hum Mol Genet</source>
          <year>2011</year>
          <volume>20</volume>
          <fpage>4879</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">21926082</pub-id>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMullan</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular karyotyping of patients with unexplained mental retardation by SNP arrays: a multicenter study</article-title>
          <source>Hum Mutat</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>1082</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">19388127</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woods</surname>
              <given-names>CG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quantification of homozygosity in consanguineous individuals with autosomal recessive disease</article-title>
          <source>Am J Hum Genet</source>
          <year>2006</year>
          <volume>78</volume>
          <fpage>889</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">16642444</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parsons</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Campos</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hirst</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Stemple</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos</article-title>
          <source>Development</source>
          <year>2002</year>
          <volume>129</volume>
          <fpage>3505</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">12091319</pub-id>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Link</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Shevchenko</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heisenberg</surname>
              <given-names>CP</given-names>
            </name>
          </person-group>
          <article-title>Proteomics of early zebrafish embryos</article-title>
          <source>BMC Dev Biol</source>
          <year>2006</year>
          <volume>6</volume>
          <fpage>1</fpage>
          <pub-id pub-id-type="pmid">16412219</pub-id>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robu</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>p53 activation by knockdown technologies</article-title>
          <source>PLoS Genet</source>
          <year>2007</year>
          <volume>3</volume>
          <fpage>e78</fpage>
          <pub-id pub-id-type="pmid">17530925</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciruna</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jenny</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mlodzik</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schier</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Planar cell polarity signalling couples cell division and morphogenesis during neurulation</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>439</volume>
          <fpage>220</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">16407953</pub-id>
        </element-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>TE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>7092</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">17438294</pub-id>
        </element-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venselaar</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Te Beek</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Kuipers</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Hekkelman</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Vriend</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces</article-title>
          <source>BMC Bioinformatics</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>548</fpage>
          <pub-id pub-id-type="pmid">21059217</pub-id>
        </element-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kemp</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Bond</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>WN</given-names>
            </name>
          </person-group>
          <article-title>Structure of a tetragonal crystal form of Escherichia coli 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2003</year>
          <volume>59</volume>
          <fpage>607</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">12595740</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Overview of genetic data in the patient cohort. (a) Schematic representation of the intragenic deletions, point mutations and homozygosity mapping data from WWS families with <italic>ISPD</italic> mutations. Ideogram of chromosome 7 showing the 3.5 Mb region of common homozygosity at band 7p21.3 flanked by SNPs rs194034 and rs818323 that was identified in family WWS-25. The position of three partially overlapping intragenic deletions in <italic>ISPD</italic> is indicated above the intron-exon structure of the gene. At the bottom the position of homozygous and compound heterozygous mutations is shown with respect to the ISPD protein domain structure. (b) Identified mutations in our total WWS/MEB cohort in number and percentage per gene. 94 families were available for research and prescreening revealed mutations in one of the six known genes in 35 families.</p>
      </caption>
      <graphic xlink:href="ukmss-47467-f0001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>MR images and muscle staining of patient WWS-160. (a) Axial T1 weighted and (b) parasagittal T2 cerebral MRIs showing hydrocephalus. (c) Muscle biopsy showed almost absent Î±DG glycosylation using IIH6 antibody in muscle in comparison to (d) IIH6 staining in a normal control muscle biopsy. (e) Spectrin staining in the patient was not visibly different from (f) normal control spectrin staining. Scale bars, 20 Î¼m.</p>
      </caption>
      <graphic xlink:href="ukmss-47467-f0002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Knockdown of zebrafish <italic>ispd</italic> recapitulates pathological defects of human WWS. (a) Compared with uninjected controls, zebrafish embryos injected with <italic>ispd</italic> MO1 (7 ng) showed characteristic hydrocephalus (asterisk) by 48 h.p.f. Scale bar, 100 Î¼m. (b) Embryos injected with <italic>ispd</italic> MO1 (7 ng) showed microphthalmia by 48 h.p.f. in comparison to controls; cell membranes were visualized by membrane-localized red fluorescent protein (mRFP). Scale bar, 100 Î¼m. (c) Eye width measurements in control (297.52Â±9.06 Î¼m, n=25) and <italic>ispd</italic> MO1 (7 ng) injected embryos (230.8Â±28.35 Î¼m, n=25; ***<italic>P</italic>= 4.68E-12). Co-injection of <italic>p53</italic> MO (6 ng) with <italic>ispd</italic> MO1 (6 ng) still resulted in reduced eye size (260.28 Â± 6.86 Î¼m, n=25; ***<italic>P</italic>= 1.39E-20), suggesting that this phenotype was not a consequence of MO off-target effects mediated by p53-induced cell death. Error bars indicate s.d. (d) Control embryos display intact muscle fibers that anchor to chevron-shaped MTJ. Embryos injected with <italic>ispd</italic> MO1 (7 ng) showed muscle fiber degeneration by 72 h.p.f. Retracting muscle fibers were revealed by condensed F-actin (arrows) and collapsed sarcolemma (visualized by mRFP). Abnormally elongated muscle fibers spanned disrupted MTJ (arrowheads) in zebrafish embryos lacking Ispd. DAPI indicates nuclei. Scale bar, 100 Î¼m.</p>
      </caption>
      <graphic xlink:href="ukmss-47467-f0003"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Hypoglycosylation of Î±DG and disrupted sarcolemma integrity in <italic>ispd</italic> MO1-injected zebrafish embryos. (a) Western blot analysis of microsome pellets and supernatant from control, <italic>ispd</italic> MO1 (7 ng) and <italic>dag1</italic> MO (5 ng) injected embryos at 48 h.p.f. Compared with control embryos, <italic>ispd</italic> MO1-injected embryos showed a reduction of glycosylated Î±DG (IIH6; 76-102 kDa) with a slight decrease of ÃDG, which is probably a secondary reduction due to protein instability caused by defective glycosylation of Î±DG as reported previously<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup>. Both glycosylated Î±DG and ÃDG were almost absent in <italic>dag1</italic> MO-injected embryos. Equal protein loading was demonstrated by Ponceau S (PonS) staining and unknown glycoproteins detected by IIH6 antibody in all three lanes (&lt;38 kDa). Equivalent amounts of Î³- and acetylated tubulins were detected in corresponding microsome supernatant. (b) Laminins remained localized at the MTJ in <italic>ispd</italic> MO1-injected embryos (7 ng). Positive fluorescent signal within degenerated muscle fibers (arrows) was probably due to disrupted sarcolemma integrity. Scale bar, 50 Î¼m. (c) MTJ-anchored muscle fibers were infiltrated by EBD in <italic>ispd</italic> MO1-injected embryos before the onset of muscle degeneration. Dashed lines indicate MTJ. DIC, differential interference contrast microscopy; ANT, anterior myotome; PST, posterior myotome. Scale bar, 50 Î¼m. (d) Injection of sub-effective doses of <italic>ispd</italic>, <italic>fktn</italic>, <italic>fkrp</italic> and control MO together or alone. Increase in the percentage of embryos with hydrocephalus suggests genetic interactions between <italic>ispd</italic>, <italic>fktn</italic> and <italic>fkrp</italic>. Each bar represents a combination of two independent experiments, scored blindly according to criteria exemplified in <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 8a</xref>. n=94â139 embryos. (e) Western blotting with IIH6 antibody showed a reduction of glycosylated Î±DG in embryos co-injected with <italic>ispd</italic> MO1 and <italic>fktn/fkrp</italic> MO as compared to control MO and <italic>ispd</italic> MO1 co-injected embryos, and single <italic>fktn</italic> or <italic>fkrp</italic> MO-injected embryos. As a negative control, almost absent Î±DG glycosylation is shown for <italic>dag1</italic> MO injected embryos.</p>
      </caption>
      <graphic xlink:href="ukmss-47467-f0004"/>
    </fig>
    <table-wrap id="T1" position="float" orientation="landscape">
      <label>Table 1</label>
      <caption>
        <p>Overview of <italic>ISPD</italic> mutations</p>
      </caption>
      <table frame="hsides" rules="rows">
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1">Family</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Diagnosis</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Genomic<break/>position chr 7<break/>(hg19)</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Mutation</th>
            <th align="left" valign="top" rowspan="1" colspan="1">State</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Exon(s)<break/>affected</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Amino acid<break/>change</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Segre-<break/>gation</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-25</td>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS/MEB</td>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16415754</td>
            <td align="left" valign="top" rowspan="1" colspan="1">c.647C&gt;A</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Homozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Ala216Asp</td>
            <td align="left" valign="top" rowspan="1" colspan="1">F, M</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-160</td>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS</td>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16078412-<break/>g.16279290</td>
            <td align="left" valign="top" rowspan="1" colspan="1">deletion<xref ref-type="table-fn" rid="TFN2">#</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">Homozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">9-10</td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">F, M</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-161</td>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS</td>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16270332-<break/>g.16324185</td>
            <td align="left" valign="top" rowspan="1" colspan="1">deletion<xref ref-type="table-fn" rid="TFN2">#</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">Homozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">6-8</td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">F, M</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-37</td>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS</td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">deletion<xref ref-type="table-fn" rid="TFN2">#</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">Homozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3-5</td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-162</td>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS</td>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16341049</td>
            <td align="left" valign="top" rowspan="1" colspan="1">c.832A&gt;T</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Homozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Lys278*</td>
            <td align="left" valign="top" rowspan="1" colspan="1">F, M</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-81</td>
            <td align="left" valign="top" rowspan="1" colspan="1">MEB</td>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16341049</td>
            <td align="left" valign="top" rowspan="1" colspan="1">c.832A&gt;T</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Homozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Lys278*</td>
            <td align="left" valign="top" rowspan="1" colspan="1">F, M</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-135</td>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS</td>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16255756</td>
            <td align="left" valign="top" rowspan="1" colspan="1">c.1186G&gt;T</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Homozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">9</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Glu396*</td>
            <td align="left" valign="top" rowspan="1" colspan="1">F, M</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-30</td>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS</td>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16460895</td>
            <td align="left" valign="top" rowspan="1" colspan="1">c.53dup</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Heterozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">1</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Ser19fs</td>
            <td align="left" valign="top" rowspan="1" colspan="1">F</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16445843</td>
            <td align="left" valign="top" rowspan="1" colspan="1">c.377G&gt;A</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Heterozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Arg126His</td>
            <td align="left" valign="top" rowspan="1" colspan="1">M</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">WWS-163</td>
            <td align="left" valign="top" rowspan="1" colspan="1">MEB</td>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16445856</td>
            <td align="left" valign="top" rowspan="1" colspan="1">c.364G&gt;C</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Heterozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Ala122Pro</td>
            <td align="left" valign="top" rowspan="1" colspan="1">M</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">g.16341079</td>
            <td align="left" valign="top" rowspan="1" colspan="1">c.802C&gt;T</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Heterozygous</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Arg268*</td>
            <td align="left" valign="top" rowspan="1" colspan="1">F</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="TFN1">
          <p id="P15">WWS, WalkerâWarburg syndrome; MEB, Muscle Eye Brain disease; F, heterozygous in father; M, heterozygous in mother; NA, not available.</p>
        </fn>
        <fn id="TFN2">
          <label>#</label>
          <p id="P16">The minimum deletion sizes are indicated. The genomic positions for WWS-160 and WWS-161 correspond to endpoints defined by SNPs that are homozygous deleted as determined by CNV analysis.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>